3M India Limited reported a net profit of Rs 522.32 crore for the financial year ended March 31, 2026, a 9.7% increase from Rs 476.07 crore in the previous year. Revenue from operations for the year rose 14.5% to Rs 5,089.76 crore. In the fourth quarter of FY26, net profit surged to Rs 215.34 crore from Rs 71.37 crore in the corresponding quarter of the previous year, while revenue grew 16.8% year-on-year to Rs 1,399.24 crore.

Operational highlights for the year included an EBITDA of Rs 1,035 crore, a 23.2% increase from the previous year. For the quarter, EBITDA rose to Rs 269 crore. The Board of Directors recommended a total dividend of Rs 506 per equity share for the financial year 2025-26. This recommended payout comprises a final dividend of Rs 160 per share and a special dividend of Rs 346 per share. The company has a face value of Rs 10 per equity share.

The Board fixed July 17, 2026, as the record date to determine shareholder eligibility for the dividend. The payout is subject to approval by shareholders at the 39th Annual General Meeting (AGM) scheduled for August 2026. If approved, the dividend will be credited or dispatched within 30 days from the date of the AGM.

The Board approved the appointment of Ms. Kavita Nair as an Additional Director effective May 27, 2026, and appointed Mr. M D Ranganath as the Chairman of the Board. Additionally, Ms. Radhika Rajan will cease to be an Independent Director upon completion of her term on May 26, 2026. The Board also reconstituted its various committees, including the Audit and Nomination and Remuneration Committees, effective May 27, 2026.

Corrigendum to Financial Results

In a corrigendum published on May 26, 2026, 3M India clarified that the unit of measure for the financial figures in its results publication should be read as "Rs. in Crores" instead of "Rs. in Lakhs". This correction applies to the note above the financial figures table in the extract of the financial results for the quarter and year ended March 31, 2026. All other contents of the publication remain unchanged.

3M India Limited has provided formal intimation regarding the cessation of Rajiv Gupta as Country Business Leader - Healthcare Business and Senior Management Personnel, effective April 30, 2026. This development follows the company's earlier announcement on April 16, 2026, about leadership changes in its healthcare division.

Cessation Details

Rajiv Gupta has formally communicated his decision to step down from his current position, effective from the close of business hours on April 30, 2026. In his resignation letter addressed to the Managing Director, Gupta stated that he will be taking up a new role within the 3M Group, necessitating his cessation as Country Business Leader - Healthcare Business and consequently as Senior Management Personnel of the company.

Leadership Transition Context

The cessation of Gupta follows the Board of Directors' approval of Jerry Daniel as the new Country Business Leader - Healthcare, effective May 1, 2026. Daniel, currently serving as Business Operations Leader - Transportation & Energy based in Pune, brings over a decade of experience within the 3M organization since 2013.

Regulatory Compliance

The intimation was made in compliance with Regulation 30 read with sub-para 7C of Para A of Part A Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The formal letter submitted by Rajiv Gupta has been enclosed as Annexure A to the regulatory filing.

The disclosure, dated April 23, 2026, was signed by Pratap Rudra Bhuvanagiri, Company Secretary & Compliance Officer, and communicated to both BSE Limited (Scrip Code: 523395) and National Stock Exchange of India Limited (Scrip Code: 3MINDIA). This communication serves as a continuation of the earlier disclosure dated April 16, 2026, regarding Gupta's transition.